Results 331 to 340 of about 43,089 (386)

Cardiac Sympathetic Nerve Activity Is Not Elevated in Ovine Hypertensive HFpEF. [PDF]

Hypertension
Chang JW, George B, Pachen M, Shanks J, Ramchandra R.   +4 more
europepmc   +1 more source

Low‐dose digoxin improves cardiac function in patients with heart failure, preserved ejection fraction and atrial fibrillation – the RATE‐AF randomized trial

European Journal of Heart Failure, EarlyView.
Summary of the change in left ventricular systolic and diastolic parameters from baseline to 12 months in patients with permanent atrial fibrillation (AF) and a left ventricular ejection fraction (LVEF) ≥50%. P‐values indicate the significance of the adjusted mean difference of the parameters at 12 months between the beta‐blocker and digoxin arm. E/e′,
Karina V. Bunting, Asgher Champsi, Simrat K. Gill, Khalil Saadeh, A. John Camm, Mary Stanbury, Sandra Haynes, Jonathon N. Townend, Richard P. Steeds, Dipak Kotecha, on behalf of the RAte control Therapy Evaluation in Permanent Atrial Fibrillation (RATE‐AF) Trial Group   +10 more
wiley   +1 more source

Does Secondary HFpEF Exist? Yes, but it Should not be Called HFpEF

Arquivos Brasileiros de Cardiologia
Humberto Villacorta, Pedro Schwartzmann
openaire   +2 more sources

Serially measured urinary albumin excretion is strongly associated with incident heart failure with preserved ejection fraction

European Journal of Heart Failure, EarlyView.
Thomas F Kok, Bart J. van Essen, Yiqian Yang, Ron T. Gansevoort, Stephan J.L. Bakker, Kevin Damman, Eric Boersma, Isabella Kardys, Adriaan A. Voors, Rudolf A. de Boer, Navin Suthahar   +10 more
wiley   +1 more source

Finerenone according to insulin resistance in heart failure: Insights from the FINEARTS‐HF trial

European Journal of Heart Failure, EarlyView.
Insulin resistance in heart failure with mildly reduced or preserved ejection fraction: insights from FINEARTS‐HF. CI, confidence interval; CV, cardiovascular; eGDR, estimated glucose disposal rate; HF, heart failure. Aims The estimated glucose disposal rate (eGDR) is a simple, non‐invasive measure of insulin resistance. In this exploratory analysis of
John W. Ostrominski, Brian L. Claggett, Akshay S. Desai, Pardeep S. Jhund, Carolyn S.P. Lam, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faiez Zannad, Bertram Pitt, Katja Rohwedder, Meike Brinker, Patrick Schloemer, John J.V. McMurray, Scott D. Solomon, Muthiah Vaduganathan   +15 more
wiley   +1 more source

Utilization of Proteomic Measures for Early Detection of Drug Benefits and Adverse Effects

The Journal of Clinical Pharmacology, EarlyView.
Abstract Recognition of benefits and adverse effects of therapies in earlier clinical trial phases could improve the safety, efficiency, and cost of clinical trials. Using four clinical trials representing a diverse set of diseases and drug classes (EXSCEL: exenatide/GLP‐1 RA, SUGAR‐DM‐HF: empagliflozin/SGLT2i, PRADA: epirubicin/anthracycline, and ...
Jessica Chadwick, Colin Berry, Meredith A. Carpenter, Geeta Gulati, Siri Lagethon Heck, Michael A. Hinterberg, Rury R. Holman, Matthew M.Y. Lee, Torbjørn Omland, Clare Paterson, Mark C. Petrie, Naveed Sattar, Svati H. Shah, Sama Shrestha, Harald Sourij, Emma V Troth, Victoria Vinje, Stephen A. Williams   +17 more
wiley   +1 more source

Understanding the Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Heart Failure. [PDF]

Card Fail Rev
Bonfioli GB, Pagnesi M, Tomasoni D, Rakisheva A, Metra M.   +4 more
europepmc   +1 more source

A geriatrician's approach to managing the complex older adult with obesity

Obesity, EarlyView.
Abstract The prevalence of obesity in older adults is rapidly increasing due to the demographic shift occurring globally. Older adults with obesity face health care challenges due to multimorbidity, functional dependency, and disability. This population often has prior history of struggles through weight‐loss attempts during the middle years of life ...
Shenbagam Dewar
wiley   +1 more source

Guideline-directed medical strategies for the co-management of heart failure and metabolic dysfunction-associated steatotic liver disease. [PDF]

Commun Med (Lond)
Gries JJ, Chen B, Bansal MB, Rodriguez M, Alqahtani SA, Brennan PN, Lang CC, Tang WHW, Lazarus JV, Krittanawong C.   +9 more
europepmc   +1 more source